FDA Inspection
Oklahoma Blood InstituteOklahoma Blood Institute – FDA Inspection, Oct 16, 2015
Record Details
This FDA Inspection record concerns Oklahoma Blood Institute, with an inspection on October 16, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Oklahoma Blood Institute
- Inspection Date
- October 16, 2015
- Product Type
- Biologics
View Company Profile
ID · 225f3689-4f73-4eae-a4d2-e8e8e1918958
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 945909
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oklahoma Blood Institute
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 8, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 27, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Oklahoma Blood Institute
- FDA Inspection 1040193 - 2017-12-07
- FDA Inspection 830972 - 2013-05-08
- FDA Inspection 727157 - 2011-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.